684 Assay development and quantitative detection of ADI-001, a CD20-targeted γδ1 CAR T therapy, using AlloCell, a universal assay for monitoring of off-the-shelf allogeneic cell therapies

• David Liu,
• Andrew Wrong,
• Blake T Aftab,
• Jackie Kennedy-Wilde,
• Lilly Wong,
• Monica Moreno,
• Collin DuBois,
• Divya Kilam,
• Natali Gulbahce,
• Monika Maleszewska,
• Yining Yi,
• Francesco Galimi,
• Rose Lai

Affiliations

David Liu

2Brisbane, Queensland, Australia

Andrew Wrong

7Atreca, Inc, San Carlos, CA, USA

Blake T Aftab

Adicet Therapeutics, Menlo Park, California, USA

Jackie Kennedy-Wilde

1Adicet Bio, Redwood City, CA, USA

Lilly Wong

2CareDx, South San Francisco, CA, USA

Monica Moreno

1Adicet Bio, Redwood City, CA, USA

Collin DuBois

2CareDx, South San Francisco, CA, USA

Divya Kilam

2CareDx, South San Francisco, CA, USA

Natali Gulbahce

2CareDx, South San Francisco, CA, USA

Monika Maleszewska

2CareDx, South San Francisco, CA, USA

Yining Yi

1Adicet Bio, Redwood City, CA, USA

Francesco Galimi

1Adicet Bio, Redwood City, CA, USA

Rose Lai

3University of Southern California, San Ramon, CA, USA